Agomelatine versus Sertraline: An Observational, Open-labeled and 12 Weeks Follow-up Study on Efficacy and Tolerability
Author:
Affiliation:
1. sychiatry Clinic, Tokat Mental Health Hospital, Tokat, Turkey
2. Department of Psychiatry, School of Medicine, Kocaeli University, Kocaeli, Turkey
3. Psychiatry Clinic, Tuzla State Hospital, Istanbul, Turkey
Publisher
Korean College of Neuropsychopharmacology
Subject
Pharmacology (medical),Behavioral Neuroscience,Psychiatry and Mental health
Link
http://pdf.medrang.co.kr/CPN2/2016/014/cpn014-04-05.pdf
Reference26 articles.
1. Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2C antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study
2. Clinical Studies on the Efficacy of Agomelatine on Depressive Symptoms
3. Olié, JP, and Kasper, S (2007). Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol. 10, 661-673.
4. Guaiana, G, Gupta, S, Chiodo, D, Davies, SJ, Haederle, K, and Koesters, M (2013). Agomelatine versus other antidepressive agents for major depression. Cochrane Database Syst Rev, CD008851.
5. A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The Effects of Fluoxetine and Agomelatine on Neurocognitive Functions and Sleep in Patients with Major Depressive Disorder;Psychiatry and Clinical Psychopharmacology;2024-03-21
2. High Probability of Gene-Drug Interactions Associated with Medication Side Effects in Adolescent Depression: Results from a Randomized Controlled Trial of Pharmacogenetic Testing;Journal of Child and Adolescent Psychopharmacology;2024-02-01
3. Comparing the effect of agomelatine and sertraline in treating patients with major depression disorder;INT ARCH HEALTH SCI;2023
4. Agomelatine: An astounding sui-generis antidepressant?;Current Molecular Pharmacology;2021-12-09
5. Acute Hepatitis Due to Agomelatine Use in Elderly Women with Depression: Case Series;Clinical Psychopharmacology and Neuroscience;2021-11-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3